Uveal MelanomaSymptoms, Doctors, Treatments, Advances & More
Learn About Uveal Melanoma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Richard Carvajal is an Oncologist practicing medicine in Lake Success, New York. Dr. Carvajal is rated as an Elite provider by MediFind in the treatment of Uveal Melanoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Tissue Biopsy. Dr. Carvajal is board certified in American Board Of Internal Medicine/Medical Oncology.
Ophthalmology - Wills Eye Hospital
Carol Shields is an Oncologist and an Ophthalmologist practicing medicine in Philadelphia, Pennsylvania. Dr. Shields is rated as an Elite provider by MediFind in the treatment of Uveal Melanoma. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Uveal Melanoma, Vitrectomy, and Iridectomy. Dr. Shields is board certified in Ophthalmology. Dr. Shields is currently accepting new patients.
Takami Sato is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Sato is rated as an Elite provider by MediFind in the treatment of Uveal Melanoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Awake Craniotomy, and Liver Embolization. Dr. Sato is currently accepting new patients.
Summary: This is a prospective, single arm, phase II clinical trial of neoadjuvant Tebentafusp (KIMMTRAK®) in patients with locally advanced primary uveal melanoma. Patients must be HLA-A\*02:01 with large, surgically unresectable (other than complete enucleation of the eye) primary uveal melanoma. The efficacy of this treatment will be assessed with the Simon's two stage design. The choice of design is gu...
Summary: The study's purpose is to establish the safety and tolerability of IMA203/IMA203CD8 products with or without combination with nivolumab in patients with solid tumors that express preferentially expressed antigen in melanoma (PRAME).